Concepedia

Donald Bodenner

DB

43

Publications

3.5K

Citations

27

H-Index

1986

Active since

Affiliations

University of Arkansas for Medical Sciences(Current)

Central Arkansas Veterans Healthcare System

University of Arkansas Medical Center

National Institute of Diabetes and Digestive and Kidney Diseases

University of South Florida

Donald Bodenner is an author at University of Arkansas for Medical Sciences specializing in medicine, endocrinology, and thyroid disorders.

Top concepts

Publications per year

1986–2018

43

Publications

43

Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors

Stavroula Kousteni, Teresita Bellido, Lilian I. Plotkin et al. · Cell · 2001 · 1.1K citations · Full text

, , +8

A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer

Martin Schlumberger, Barbara Jarząb, Maria E. Cabanillas et al. · Clinical Cancer Research · 2015 · 244 citations · Full text

A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine‐refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment

Maria E. Cabanillas, Martin Schlumberger, Barbara Jarząb et al. · Cancer · 2015 · 185 citations · Full text

Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition.

Donald Bodenner, Peter C. Dedon, Peter C. Keng et al. · PubMed · 1986 · 180 citations

, , +17

Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.

Donald Bodenner, Peter C. Dedon, Peter C. Keng et al. · PubMed · 1986 · 157 citations

, , +17

Rows per page

1–5 of 43